The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS)

  01 September 2019

Proportions of vancomycin resistance in clinical E. faecium isolates from German hospitals are increasing underlining the growing significance of E. faecium infections for public health. VREF proportions differ considerable among German regions with a particular focus of high vancomycin resistance in Southwest and Southeast Germany. Continued surveillance and implementation of effective infection prevention and control measures accounting for local resistance differences are needed to reduce the spread of vancomycin-resistant E. faecium in German hospitals.

Author(s): Robby Markwart, Niklas Willrich, Sebastian Haller, Ines Noll, Uwe Koppe, Guido Werner, Tim Eckmanns & Annicka Reuss
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!